Northwest Bank & Trust Co Invests $551,000 in Bath & Body Works, Inc. (NYSE:BBWI)

Northwest Bank & Trust Co purchased a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 12,779 shares of the company’s stock, valued at approximately $551,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. TD Asset Management Inc raised its position in shares of Bath & Body Works by 3.7% during the 4th quarter. TD Asset Management Inc now owns 976,278 shares of the company’s stock worth $42,136,000 after purchasing an additional 35,261 shares during the period. Frazier Financial Advisors LLC acquired a new stake in shares of Bath & Body Works during the 4th quarter worth approximately $1,618,000. Pearl River Capital LLC raised its position in shares of Bath & Body Works by 145.6% during the 3rd quarter. Pearl River Capital LLC now owns 31,364 shares of the company’s stock worth $1,060,000 after purchasing an additional 18,596 shares during the period. Impax Asset Management Group plc raised its position in shares of Bath & Body Works by 305.6% during the 4th quarter. Impax Asset Management Group plc now owns 356,910 shares of the company’s stock worth $15,404,000 after purchasing an additional 268,913 shares during the period. Finally, Trexquant Investment LP acquired a new stake in shares of Bath & Body Works during the 4th quarter worth approximately $4,450,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Bath & Body Works

In other news, insider Thomas E. Mazurek sold 4,285 shares of Bath & Body Works stock in a transaction dated Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total value of $209,493.65. Following the transaction, the insider now directly owns 45,992 shares in the company, valued at $2,248,548.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.27% of the stock is currently owned by corporate insiders.

Bath & Body Works Price Performance

BBWI traded down $0.52 during trading on Friday, reaching $43.26. 2,215,417 shares of the stock traded hands, compared to its average volume of 3,081,114. The stock has a market cap of $9.66 billion, a price-to-earnings ratio of 11.15, a price-to-earnings-growth ratio of 1.45 and a beta of 1.90. Bath & Body Works, Inc. has a fifty-two week low of $27.30 and a fifty-two week high of $52.99. The stock’s 50-day simple moving average is $46.73 and its two-hundred day simple moving average is $44.77.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Tuesday, June 4th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.05. Bath & Body Works had a negative return on equity of 40.00% and a net margin of 11.92%. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.37 billion. During the same quarter last year, the firm earned $0.33 earnings per share. The business’s revenue for the quarter was down .9% on a year-over-year basis. Research analysts anticipate that Bath & Body Works, Inc. will post 3.29 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Stockholders of record on Friday, June 7th will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, June 7th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.85%. Bath & Body Works’s payout ratio is presently 20.62%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. JPMorgan Chase & Co. raised Bath & Body Works from an “underweight” rating to a “neutral” rating and increased their price objective for the stock from $40.00 to $53.00 in a report on Friday, May 17th. Robert W. Baird increased their price objective on Bath & Body Works from $50.00 to $54.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. UBS Group increased their price objective on Bath & Body Works from $46.00 to $52.00 and gave the stock a “neutral” rating in a report on Monday, March 4th. The Goldman Sachs Group increased their price objective on Bath & Body Works from $49.00 to $56.00 and gave the stock a “buy” rating in a report on Monday, March 4th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Bath & Body Works from $53.00 to $57.00 in a report on Monday, June 3rd. Eight equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $48.53.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.